FindTrial
Sign In

Randomised, placebo controlled study of the effect of sildenafil on hypoxia-induced pulmonary hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN41186152
Enrollment
Unknown
Registered
2002-03-08
Start date
2001-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia-induced pulmonary hypertension Circulatory System Hypertension

Interventions

1. Placebo tds for 3 months 2. Sildenafil 25 mg tds for 3 months, or 3. Sildenafil 100 mg tds for 3 months

Sponsors

British Heart Foundation (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males or females aged 18 years and over 2. Resting pulmonary artery pressure =25 mmHg 3. Written informed consent must be obtained by the investigator before the subject is screened for the study

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026